|
Arix Bioscience PLC - venture capital company focused on investing in breakthrough biotechnology companies - Reports a net asset value per share of £1.84 as at July 31, down from £1.86 as at June 30. Listed portfolio value falls to £69 million as at July 31 from £71.2 million as at June 30. Current stock price: 117.25 pence, up 0.6% in London on Monday morning 12-month change: up 5.2% Copyright 2023 Alliance News Ltd. All Rights Reserved.
|
